DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Proteomics of ovarian cancer: functional insights and clinical applications

Abstract

In the past decade, there has been an increasing interest in applying proteomics to assist in understanding the pathogenesis of ovarian cancer, elucidating the mechanism of drug resistance, and in the development of biomarkers for early detection of ovarian cancer. Although ovarian cancer is a spectrum of different diseases, the strategies for diagnosis and treatment with surgery and adjuvant therapy are similar across ovarian cancer types, increasing the general applicability of discoveries made through proteomics research. While proteomic experiments face many difficulties which slow the pace of clinical applications, recent advances in proteomic technology contribute significantly to the identification of aberrant proteins and networks which can serve as targets for biomarker development and individualized therapies. This review provides a summary of the literature on proteomics’ contributions to ovarian cancer research and highlights the current issues, future directions, and challenges. In conclusion, we propose that protein-level characterization of primary lesion in ovarian cancer can decipher the mystery of this disease, improve diagnostic tools, and lead to more effective screening programs.

Authors:
 [1];  [2]
  1. Egybiotech for Research and Biotechnology, Alexandria (Egypt); Pacific Northwest National Lab. (PNNL), Richland, WA (United States). Biological Sciences Division
  2. Pacific Northwest National Lab. (PNNL), Richland, WA (United States). Biological Sciences Division
Publication Date:
Research Org.:
Pacific Northwest National Laboratory (PNNL), Richland, WA (United States). Environmental Molecular Sciences Laboratory (EMSL)
Sponsoring Org.:
USDOE; National Cancer Institute (NCI); National Inst.of Health (NIH)
OSTI Identifier:
1208724
Report Number(s):
PNNL-SA-111055
Journal ID: ISSN 0167-7659; 48666; 400412000
Grant/Contract Number:  
AC05-76RL01830; 5U24 CA160019-03; ACN12003-001-00000
Resource Type:
Accepted Manuscript
Journal Name:
Cancer and Metastasis Reviews
Additional Journal Information:
Journal Volume: 34; Journal Issue: 1; Journal ID: ISSN 0167-7659
Publisher:
Springer
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; 59 BASIC BIOLOGICAL SCIENCES; Ovarian cancer; Proteomics; Biomarker; Drug resistance; Subtypes; Environmental Molecular Sciences Laboratory

Citation Formats

Elzek, Mohamed A., and Rodland, Karin D. Proteomics of ovarian cancer: functional insights and clinical applications. United States: N. p., 2015. Web. doi:10.1007/s10555-014-9547-8.
Elzek, Mohamed A., & Rodland, Karin D. Proteomics of ovarian cancer: functional insights and clinical applications. United States. https://doi.org/10.1007/s10555-014-9547-8
Elzek, Mohamed A., and Rodland, Karin D. Wed . "Proteomics of ovarian cancer: functional insights and clinical applications". United States. https://doi.org/10.1007/s10555-014-9547-8. https://www.osti.gov/servlets/purl/1208724.
@article{osti_1208724,
title = {Proteomics of ovarian cancer: functional insights and clinical applications},
author = {Elzek, Mohamed A. and Rodland, Karin D.},
abstractNote = {In the past decade, there has been an increasing interest in applying proteomics to assist in understanding the pathogenesis of ovarian cancer, elucidating the mechanism of drug resistance, and in the development of biomarkers for early detection of ovarian cancer. Although ovarian cancer is a spectrum of different diseases, the strategies for diagnosis and treatment with surgery and adjuvant therapy are similar across ovarian cancer types, increasing the general applicability of discoveries made through proteomics research. While proteomic experiments face many difficulties which slow the pace of clinical applications, recent advances in proteomic technology contribute significantly to the identification of aberrant proteins and networks which can serve as targets for biomarker development and individualized therapies. This review provides a summary of the literature on proteomics’ contributions to ovarian cancer research and highlights the current issues, future directions, and challenges. In conclusion, we propose that protein-level characterization of primary lesion in ovarian cancer can decipher the mystery of this disease, improve diagnostic tools, and lead to more effective screening programs.},
doi = {10.1007/s10555-014-9547-8},
journal = {Cancer and Metastasis Reviews},
number = 1,
volume = 34,
place = {United States},
year = {Wed Mar 04 00:00:00 EST 2015},
month = {Wed Mar 04 00:00:00 EST 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 42 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Mining the Ovarian Cancer Ascites Proteome for Potential Ovarian Cancer Biomarkers
journal, December 2008

  • Kuk, Cynthia; Kulasingam, Vathany; Gunawardana, C. Geeth
  • Molecular & Cellular Proteomics, Vol. 8, Issue 4
  • DOI: 10.1074/mcp.M800313-MCP200

Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy
journal, March 2005


Application of systems biology principles to protein biomarker discovery: Urinary exosomal proteome in renal transplantation
journal, June 2012

  • Pisitkun, Trairak; Gandolfo, Maria T.; Das, Samarjit
  • PROTEOMICS - Clinical Applications, Vol. 6, Issue 5-6
  • DOI: 10.1002/prca.201100108

Genomic Predictors of Outcome and Treatment Response in Breast Cancer
journal, April 2009

  • Dunn, Lara; DeMichele, Angela
  • Molecular Diagnosis & Therapy, Vol. 13, Issue 2
  • DOI: 10.1007/BF03256317

Proteomic analyses of serous and endometrioid epithelial ovarian cancers - Cases studies - Molecular insights of a possible histological etiology of serous ovarian cancer
journal, June 2013

  • Longuespée, Rémi; Gagnon, Hugo; Boyon, Charlotte
  • PROTEOMICS - Clinical Applications, Vol. 7, Issue 5-6
  • DOI: 10.1002/prca.201200079

Therapeutic strategies in epithelial ovarian cancer
journal, January 2012

  • Kim, Ayako; Ueda, Yutaka; Naka, Tetsuji
  • Journal of Experimental & Clinical Cancer Research, Vol. 31, Issue 1
  • DOI: 10.1186/1756-9966-31-14

Label-Free LC-MSe in Tissue and Serum Reveals Protein Networks Underlying Differences between Benign and Malignant Serous Ovarian Tumors
journal, September 2014


Proteomic Identification of Paclitaxel-Resistance Associated hnRNP A2 and GDI 2 Proteins in Human Ovarian Cancer Cells
journal, November 2010

  • Lee, Dong Hyeon; Chung, Kwanghoe; Song, Ji-Ae
  • Journal of Proteome Research, Vol. 9, Issue 11
  • DOI: 10.1021/pr100478u

Identification of Platinum-Resistance Associated Proteins through Proteomic Analysis of Human Ovarian Cancer Cells and Their Platinum-Resistant Sublines
journal, February 2007

  • Yan, Xue-dong; Pan, Ling-ya; Yuan, Ye
  • Journal of Proteome Research, Vol. 6, Issue 2
  • DOI: 10.1021/pr060402r

Historical perspective of peptidomics
journal, June 2014


Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present
journal, July 2012

  • Bantscheff, Marcus; Lemeer, Simone; Savitski, Mikhail M.
  • Analytical and Bioanalytical Chemistry, Vol. 404, Issue 4
  • DOI: 10.1007/s00216-012-6203-4

Identification and proteomic profiling of exosomes in human cerebrospinal fluid
journal, January 2012

  • Street, Jonathan M.; Barran, Perdita E.; Mackay, C. Logan
  • Journal of Translational Medicine, Vol. 10, Issue 1
  • DOI: 10.1186/1479-5876-10-5

Proteomic analysis of post-translational modifications
journal, March 2003

  • Mann, Matthias; Jensen, Ole N.
  • Nature Biotechnology, Vol. 21, Issue 3
  • DOI: 10.1038/nbt0303-255

Genomic signatures to guide the use of chemotherapeutics
journal, October 2006

  • Potti, Anil; Dressman, Holly K.; Bild, Andrea
  • Nature Medicine, Vol. 12, Issue 11
  • DOI: 10.1038/nm1491

Investigation of the Ovarian and Prostate Cancer Peptidome for Candidate Early Detection Markers Using a Novel Nanoparticle Biomarker Capture Technology
journal, June 2010

  • Fredolini, Claudia; Meani, Francesco; Luchini, Alessandra
  • The AAPS Journal, Vol. 12, Issue 4
  • DOI: 10.1208/s12248-010-9211-3

Ovarian cancer molecular pathology
journal, June 2012

  • Longuespée, Rémi; Boyon, C.; Desmons, Annie
  • Cancer and Metastasis Reviews, Vol. 31, Issue 3-4
  • DOI: 10.1007/s10555-012-9383-7

Comparative Proteomic Analysis of Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line and Its Resistant Counterpart A2780TC1 by 2D-DIGE: The Role of ERp57
journal, April 2009

  • Cicchillitti, Lucia; Di Michele, Michela; Urbani, Andrea
  • Journal of Proteome Research, Vol. 8, Issue 4
  • DOI: 10.1021/pr800856b

Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
journal, December 2008


Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays
journal, April 2004

  • Berchuck, Andrew; Iversen, Edwin S.; Lancaster, Johnathan M.
  • American Journal of Obstetrics and Gynecology, Vol. 190, Issue 4
  • DOI: 10.1016/j.ajog.2004.02.005

Diverse Tumorigenic Pathways in Ovarian Serous Carcinoma
journal, April 2002


Proteomics by Mass Spectrometry: Approaches, Advances, and Applications
journal, August 2009


The dynamic range problem in the analysis of the plasma proteome
journal, January 2010


Quantitative Proteomics Analysis Identifies Mitochondria as Therapeutic Targets of Multidrug-Resistance in Ovarian Cancer
journal, January 2014

  • Chen, Xiulan; Wei, Shasha; Ma, Ying
  • Theranostics, Vol. 4, Issue 12
  • DOI: 10.7150/thno.8502

Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass
journal, June 2010


Exosomes: an overview of biogenesis, composition and role in ovarian cancer
journal, January 2014

  • Beach, Allison; Zhang, Huang-Ge; Ratajczak, Mariusz Z.
  • Journal of Ovarian Research, Vol. 7, Issue 1
  • DOI: 10.1186/1757-2215-7-14

Toward improving the proteomic analysis of formalin-fixed, paraffin-embedded tissue
journal, August 2013

  • Fowler, Carol B.; O’Leary, Timothy J.; Mason, Jeffrey T.
  • Expert Review of Proteomics, Vol. 10, Issue 4
  • DOI: 10.1586/14789450.2013.820531

Proteomic analysis reflects different histologic subtypes of epithelial ovarian cancer
journal, March 2012


A database of mass spectrometric assays for the yeast proteome
journal, November 2008

  • Picotti, Paola; Lam, Henry; Campbell, David
  • Nature Methods, Vol. 5, Issue 11
  • DOI: 10.1038/nmeth1108-913

Differential Exoprotease Activities Confer Tumor-Specific Serum Peptidome Patterns
journal, April 2006


Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian Carcinomas
journal, March 2005


Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ
journal, April 2013

  • Kristjansdottir, Björg; Levan, Kristina; Partheen, Karolina
  • Clinical Proteomics, Vol. 10, Issue 1
  • DOI: 10.1186/1559-0275-10-4

Glycoproteomic identification of potential glycoprotein biomarkers in ovarian cancer proximal fluids
journal, January 2013

  • Kuzmanov, Uros; Musrap, Natasha; Kosanam, Hari
  • Clinical Chemistry and Laboratory Medicine, Vol. 51, Issue 7
  • DOI: 10.1515/cclm-2012-0642

CA125 surveillance increases optimal resectability at secondary cytoreductive surgery for recurrent epithelial ovarian cancer
journal, May 2011


Integrated Proteomic Analysis of Human Cancer Cells and Plasma from Tumor Bearing Mice for Ovarian Cancer Biomarker Discovery
journal, November 2009


Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer
journal, January 2011


HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
journal, February 2011

  • Van Gorp, T.; Cadron, I.; Despierre, E.
  • British Journal of Cancer, Vol. 104, Issue 5
  • DOI: 10.1038/sj.bjc.6606092

Origin and Pathogenesis of Pelvic (Ovarian, Tubal, and Primary Peritoneal) Serous Carcinoma
journal, January 2014


Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics
journal, November 2011


Prediction of optimal versus suboptimal cytoreduction of advanced-stage serious ovarian cancer with the use of microarrays
journal, September 2004


Mass spectrometry-based proteomics
journal, March 2003


Comprehensive Analysis of Conditioned Media from Ovarian Cancer Cell Lines Identifies Novel Candidate Markers of Epithelial Ovarian Cancer
journal, October 2009

  • Gunawardana, C. Geeth; Kuk, Cynthia; Smith, Chris R.
  • Journal of Proteome Research, Vol. 8, Issue 10
  • DOI: 10.1021/pr900411g

A Proteome Resource of Ovarian Cancer Ascites: Integrated Proteomic and Bioinformatic Analyses To Identify Putative Biomarkers
journal, January 2008

  • Gortzak-Uzan, Limor; Ignatchenko, Alex; Evangelou, Andreas I.
  • Journal of Proteome Research, Vol. 7, Issue 1
  • DOI: 10.1021/pr0703223

The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: A systematic review
journal, June 2007


In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome
journal, March 2014

  • Sinha, Ankit; Ignatchenko, Vladimir; Ignatchenko, Alex
  • Biochemical and Biophysical Research Communications, Vol. 445, Issue 4
  • DOI: 10.1016/j.bbrc.2013.12.070

A Xenograft Mouse Model Coupled with In-depth Plasma Proteome Analysis Facilitates Identification of Novel Serum Biomarkers for Human Ovarian Cancer
journal, November 2011

  • Tang, Hsin-Yao; Beer, Lynn A.; Chang-Wong, Tony
  • Journal of Proteome Research, Vol. 11, Issue 2
  • DOI: 10.1021/pr200603h

Proteogenomic characterization of human colon and rectal cancer
journal, July 2014

  • Zhang, Bing; Wang, Jing; Wang, Xiaojing
  • Nature, Vol. 513, Issue 7518
  • DOI: 10.1038/nature13438

Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling
journal, September 2010

  • Chairoungdua, Arthit; Smith, Danielle L.; Pochard, Pierre
  • The Journal of Cell Biology, Vol. 190, Issue 6
  • DOI: 10.1083/jcb.201002049

Variation and genetic control of protein abundance in humans
journal, May 2013

  • Wu, Linfeng; Candille, Sophie I.; Choi, Yoonha
  • Nature, Vol. 499, Issue 7456
  • DOI: 10.1038/nature12223

Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence
journal, June 2004

  • Blom, Nikolaj; Sicheritz-Pontén, Thomas; Gupta, Ramneek
  • PROTEOMICS, Vol. 4, Issue 6
  • DOI: 10.1002/pmic.200300771

LC−MS/MS Analysis of Ovarian Cancer Metastasis-Related Proteins Using a Nude Mouse Model: 14-3-3 Zeta as a Candidate Biomarker
journal, December 2010

  • He, Yifeng; Wu, Xin; Liu, Xiaohui
  • Journal of Proteome Research, Vol. 9, Issue 12
  • DOI: 10.1021/pr100822v

Integrated genomic analyses of ovarian carcinoma
journal, June 2011


Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer
journal, October 2005


Lessons from BRCA: The Tubal Fimbria Emerges as an Origin for Pelvic Serous Cancer
journal, March 2007

  • Crum, C. P.; Drapkin, R.; Kindelberger, D.
  • Clinical Medicine & Research, Vol. 5, Issue 1
  • DOI: 10.3121/cmr.2007.702

PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies
journal, January 2014

  • Lee, J-m.; Ledermann, J. A.; Kohn, E. C.
  • Annals of Oncology, Vol. 25, Issue 1
  • DOI: 10.1093/annonc/mdt384

The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
journal, January 2010


Evaluating cell lines as tumour models by comparison of genomic profiles
journal, July 2013

  • Domcke, Silvia; Sinha, Rileen; Levine, Douglas A.
  • Nature Communications, Vol. 4, Issue 1
  • DOI: 10.1038/ncomms3126

A proteomic kinetic analysis of IGROV1 ovarian carcinoma cell line response to cisplatin treatment
journal, November 2007


Proteomic Analysis of Urinary Exosomes in Cardiovascular and Associated Kidney Diseases by Two-Dimensional Electrophoresis and LC–MS/MS
book, January 2013


Integrated genomic analyses of ovarian carcinoma
text, January 2011

  • Charles, Perou,
  • The University of North Carolina at Chapel Hill University Libraries
  • DOI: 10.17615/hvp3-wg08

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
journal, April 2005

  • Farmer, Hannah; McCabe, Nuala; Lord, Christopher J.
  • Nature, Vol. 434, Issue 7035
  • DOI: 10.1038/nature03445

Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines
journal, October 2010


Comparative Proteomics of Ovarian Epithelial Tumors
journal, May 2006

  • An, Hee Jung; Kim, Dong Su; Park, Yong Kyu
  • Journal of Proteome Research, Vol. 5, Issue 5
  • DOI: 10.1021/pr050461p

Characterization of serum biomarkers for detection of early stage ovarian cancer
journal, October 2005

  • Kozak, Katherine R.; Su, Feng; Whitelegge, Julian P.
  • PROTEOMICS, Vol. 5, Issue 17
  • DOI: 10.1002/pmic.200500093

Global quantification of mammalian gene expression control
journal, May 2011

  • Schwanhäusser, Björn; Busse, Dorothea; Li, Na
  • Nature, Vol. 473, Issue 7347
  • DOI: 10.1038/nature10098

In 2014, can we do better than CA125 in the early detection of ovarian cancer?
journal, January 2014


A randomized study of screening for ovarian cancer: a multicenter study in Japan
journal, May 2008


Gene Expression Signature With Independent Prognostic Significance in Epithelial Ovarian Cancer
journal, December 2004

  • Spentzos, Dimitrios; Levine, Douglas A.; Ramoni, Marco F.
  • Journal of Clinical Oncology, Vol. 22, Issue 23
  • DOI: 10.1200/JCO.2004.04.070

Early Detection of Ovarian Cancer: Promise and Reality
book, January 2002


Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship
journal, January 2007


Biomarker Failures
journal, January 2013


Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines
journal, March 2011

  • Dai, Zhiqin; Yin, Jie; He, Haojie
  • PROTEOMICS - Clinical Applications, Vol. 5, Issue 3-4
  • DOI: 10.1002/prca.201190016

Glycoproteomics of paclitaxel resistance in human epithelial ovarian cancer cell lines: Towards the identification of putative biomarkers
journal, March 2010


Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review
journal, May 2013

  • Azmi, Asfar S.; Bao, Bin; Sarkar, Fazlul H.
  • Cancer and Metastasis Reviews, Vol. 32, Issue 3-4
  • DOI: 10.1007/s10555-013-9441-9

Investigation of ovarian cancer associated sialylation changes in N-linked glycopeptides by quantitative proteomics
journal, January 2012

  • Shetty, Vivekananda; Hafner, Julie; Shah, Punit
  • Clinical Proteomics, Vol. 9, Issue 1
  • DOI: 10.1186/1559-0275-9-10

Gene-expression profiling in epithelial ovarian cancer
journal, July 2008

  • Konstantinopoulos, Panagiotis A.; Spentzos, Dimitrios; Cannistra, Stephen A.
  • Nature Clinical Practice Oncology, Vol. 5, Issue 10
  • DOI: 10.1038/ncponc1178

Molecular Cloning of the CA125 Ovarian Cancer Antigen: IDENTIFICATION AS A NEW MUCIN, MUC16
journal, May 2001

  • Yin, Beatrice W. T.; Lloyd, Kenneth O.
  • Journal of Biological Chemistry, Vol. 276, Issue 29
  • DOI: 10.1074/jbc.M103554200

Ovarian cancer: strategies for overcoming resistance to chemotherapy
journal, July 2003

  • Agarwal, Roshan; Kaye, Stan B.
  • Nature Reviews Cancer, Vol. 3, Issue 7
  • DOI: 10.1038/nrc1123

Studies of the ‘hook’ effect in the one-step sandwich immunoassay
journal, July 1992


Exosomes with Immune Modulatory Features Are Present in Human Breast Milk
journal, July 2007

  • Admyre, Charlotte; Johansson, Sara M.; Qazi, Khaleda Rahman
  • The Journal of Immunology, Vol. 179, Issue 3
  • DOI: 10.4049/jimmunol.179.3.1969

HE4 in ovarian cancer
book, September 2011


Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
journal, July 2011


A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
journal, January 2009


Laser-capture microdissection
journal, June 2006

  • Espina, Virginia; Wulfkuhle, Julia D.; Calvert, Valerie S.
  • Nature Protocols, Vol. 1, Issue 2
  • DOI: 10.1038/nprot.2006.85

Phosphoproteomics in cancer
journal, September 2010


The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
journal, January 2011

  • Montagnana, Martina; Danese, Elisa; Ruzzenente, Orazio
  • Clinical Chemistry and Laboratory Medicine, Vol. 49, Issue 3
  • DOI: 10.1515/CCLM.2011.075

Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis
journal, September 2010

  • Abbott, Karen L.; Lim, Jae-Min; Wells, Lance
  • PROTEOMICS - Clinical Applications, Vol. 4, Issue 8-9
  • DOI: 10.1002/prca.201090032

Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma
journal, November 2006

  • Morita, Atsushi; Miyagi, Etsuko; Yasumitsu, Hidetaro
  • PROTEOMICS, Vol. 6, Issue 21
  • DOI: 10.1002/pmic.200500708

Reverse-phase protein lysate microarrays for cell signaling analysis
journal, October 2008

  • Spurrier, Brett; Ramalingam, Sundhar; Nishizuka, Satoshi
  • Nature Protocols, Vol. 3, Issue 11
  • DOI: 10.1038/nprot.2008.179

Extracellular vesicles: biology and emerging therapeutic opportunities
journal, April 2013

  • EL Andaloussi, Samir; Mäger, Imre; Breakefield, Xandra O.
  • Nature Reviews Drug Discovery, Vol. 12, Issue 5
  • DOI: 10.1038/nrd3978

Comparative proteome analysis of human epithelial ovarian cancer
journal, January 2007

  • Gagné, Jean-Philippe; Éthier, Chantal; Gagné, Pierre
  • Proteome Science, Vol. 5, Issue 1
  • DOI: 10.1186/1477-5956-5-16

Gene Expression Patterns in Ovarian Carcinomas
journal, November 2003

  • Schaner, Marci E.; Ross, Douglas T.; Ciaravino, Giuseppe
  • Molecular Biology of the Cell, Vol. 14, Issue 11
  • DOI: 10.1091/mbc.E03-05-0279

Classifications of ovarian cancer tissues by proteomic patterns
journal, November 2006


Beyond chemotherapy: targeted therapies in ovarian cancer
journal, March 2009

  • Yap, Timothy A.; Carden, Craig P.; Kaye, Stan B.
  • Nature Reviews Cancer, Vol. 9, Issue 3
  • DOI: 10.1038/nrc2583

Enrichment techniques employed in phosphoproteomics
journal, October 2011


Characterization and proteomic analysis of ovarian cancer-derived exosomes
journal, March 2013


Screening for Ovarian Cancer: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement
journal, December 2012


Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study
journal, January 2009


Proteomic Analysis of Ovarian Cancer Cells Reveals Dynamic Processes of Protein Secretion and Shedding of Extra-Cellular Domains
journal, June 2008


Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology
journal, January 2009

  • Petri, Anette Lykke; Simonsen, Anja Hviid; Yip, Tai-Tung
  • Acta Obstetricia et Gynecologica Scandinavica, Vol. 88, Issue 1
  • DOI: 10.1080/00016340802443830

Mitochondrial Proteomic Analysis of Cisplatin Resistance in Ovarian Cancer
journal, August 2012

  • Chappell, Nicole P.; Teng, Pang-ning; Hood, Brian L.
  • Journal of Proteome Research, Vol. 11, Issue 9
  • DOI: 10.1021/pr300403d

Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian Tumors
journal, January 2011

  • Ueland, Frederick R.; Desimone, Christopher P.; Seamon, Leigh G.
  • Obstetrics & Gynecology, Vol. 117, Issue 6
  • DOI: 10.1097/AOG.0b013e31821b5118

The cell of origin of ovarian epithelial tumours
journal, December 2008


A Randomized Study of Screening for Ovarian Cancer: A Multicenter Study in Japan
journal, January 2008


Assessing the clinical utility of cancer genomic and proteomic data across tumor types
journal, June 2014

  • Yuan, Yuan; Van Allen, Eliezer M.; Omberg, Larsson
  • Nature Biotechnology, Vol. 32, Issue 7
  • DOI: 10.1038/nbt.2940

Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases
journal, November 2011


Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer
journal, August 2004


The ovarian cancer-derived secretory/releasing proteome: A repertoire of tumor markers
journal, June 2012


Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass
journal, January 2011

  • Moore, Richard G.; Miller, M. Craig; Disilvestro, Paul
  • Obstetrics & Gynecology, Vol. 118, Issue 2, Part 1
  • DOI: 10.1097/AOG.0b013e318224fce2

Highlights on the capacities of "Gel-based" proteomics
journal, January 2010


An overview of biomarkers for the ovarian cancer diagnosis
journal, October 2011

  • Zhang, Bei; Cai, Feng Feng; Zhong, Xiao Yan
  • European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 158, Issue 2
  • DOI: 10.1016/j.ejogrb.2011.04.023

Application of laser capture microdissection and proteomics in colon cancer
journal, August 2001


Differential exoprotease activities confer tumor-specific serum peptidome patterns
journal, December 2005

  • Villanueva, Josep; Shaffer, David R.; Philip, John
  • Journal of Clinical Investigation, Vol. 116, Issue 1, p. 271-284
  • DOI: 10.1172/JCI26022

Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect of lysosomotropic agents.
journal, August 1983


Works referencing / citing this record:

Novel Approaches in Ovarian Cancer Research against Heterogeneity, Late Diagnosis, Drug Resistance, and Transcoelomic Metastases
journal, May 2019

  • Erol, Anna; Niemira, Magdalena; Krętowski, Adam Jacek
  • International Journal of Molecular Sciences, Vol. 20, Issue 11
  • DOI: 10.3390/ijms20112649

Sample Treatment for Saliva Proteomics
book, June 2019

  • Amado, Francisco; Calheiros-Lobo, Maria João; Ferreira, Rita
  • Advances in Experimental Medicine and Biology
  • DOI: 10.1007/978-3-030-12298-0_2

MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer
journal, July 2017


Highly-accurate metabolomic detection of early-stage ovarian cancer
journal, November 2015

  • Gaul, David A.; Mezencev, Roman; Long, Tran Q.
  • Scientific Reports, Vol. 5, Issue 1
  • DOI: 10.1038/srep16351

MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer
journal, July 2017


Targeted metabolomic profiling of low and high grade serous epithelial ovarian cancer tissues: a pilot study
journal, November 2018


Quantitative Profiling of Single Formalin Fixed Tumour Sections: proteomics for translational research
journal, October 2016

  • Hughes, Christopher S.; McConechy, Melissa K.; Cochrane, Dawn R.
  • Scientific Reports, Vol. 6, Issue 1
  • DOI: 10.1038/srep34949

Mass spectrometry-based proteomics techniques and their application in ovarian cancer research
journal, October 2018


Highly-accurate metabolomic detection of early-stage ovarian cancer
journal, November 2015

  • Gaul, David A.; Mezencev, Roman; Long, Tran Q.
  • Scientific Reports, Vol. 5, Issue 1
  • DOI: 10.1038/srep16351

20(S)-Rg3 blocked epithelial-mesenchymal transition through DNMT3A/miR-145/FSCN1 in ovarian cancer
journal, June 2017


miR-30d Blocked Transforming Growth Factor β1–Induced Epithelial-Mesenchymal Transition by Targeting Snail in Ovarian Cancer Cells
journal, November 2015


Quantitative Profiling of Single Formalin Fixed Tumour Sections: proteomics for translational research
journal, October 2016

  • Hughes, Christopher S.; McConechy, Melissa K.; Cochrane, Dawn R.
  • Scientific Reports, Vol. 6, Issue 1
  • DOI: 10.1038/srep34949